Lyell Immunopharma, Inc. (30) | Business Operations (4)
Browse by Subcategory
Recent Contracts
-
Second Amendment to the Collaboration and License Agreement between the Registrant, GlaxoSmithKline Intellectual Property (No.5) Limited and Glaxo Group Limited, dated December...
(Filed With SEC on March 29, 2022)
-
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
(Filed With SEC on May 25, 2021)
-
Collaboration and License Agreement by and between the Registrant, GlaxoSmithKline Intellectual Property (No. 5) Limited and Glaxo Group Limited, dated May 23, 2019, as amended
(Filed With SEC on June 9, 2021)
-
Collaboration and License Agreement by and between the Registrant, GlaxoSmithKline Intellectual Property (No. 5) Limited and Glaxo Group Limited, dated May 23, 2019, as amended
(Filed With SEC on May 25, 2021)